Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials
- PMID: 34125567
- PMCID: PMC8210460
- DOI: 10.1161/CIRCULATIONAHA.120.050034
Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials
Keywords: cholesterol; clinical trial; primary prevention; secondary prevention.
Conflict of interest statement
Conflict of Interest Disclosures
None
Figures
References
-
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:3168–3209. - PubMed
-
- United States Census Bureau. QuickFacts. Census.gov. 2018. Available at https://www.census.gov/quickfacts/fact/table/US/PST045219. Accessed July 3, 2020.
-
- United States Census Bureau. US Population - 1940 to 2010. Census.gov. 2012. Available at https://www.census.gov/newsroom/cspan/1940census/CSPAN_1940slides.pdf. Accessed July 3, 2020.
-
- Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, et al. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry. JAMA Cardiol. 2018;3:739–748. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
